Thuy Tran
About me
- I obtained a PhD in 2009 from Uppsala University and received my Docent/readership in 2016 from Lund University in experimental oncology with a focus on molecular imaging and radiochemistry.
I have more than 14 years’ experience in both preclinical and clinical research in the fields of nuclear medicine, radionuclide production, molecular imaging, and antibody-based theranostics. Currently, I lead the TRANslational Theranostics group, which is dedicated to advancing theranostics - an elegant approach that seamlessly integrates diagnostics and therapy in one solution, revolutionizing precision medicine in cancer management.
Education:
2016 Docent in experimental oncology, Lund University
2009 Ph.D. Degree, specialized in Molecular imaging and radiometal chemistry, Uppsala University
2008 Master Degree in Medical radionuclide techniques, Uppsala University
2005 Master of Science in Pharmacy, Uppsala University
Research
My research group focuses on the development of theranostics, i.e. radiopharmaceuticals for precision diagnostics, therapy and monitoring of diseases, with the emphasis in oncological diseases. We conduct studies to identify new targets and screen for new drugs for cancer treatments. In parallel, we perform novel developments of non-conventional radiometals using solid target on cyclotron, novel radiotracer developments, and biological evaluation studies in vitro and in vivo to clinical translation.
We are a multidisciplinary team consisting of pharmacists, radiochemists, medicine doctoral students, medical physicists and biologists. We collaborate closely and broadly with other research groups for generating drug screening, target identification, and clinicians, oncologists, and radiologists for clinical translation.
Articles
- Article: JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY. 2024;52(3):221-228
- Article: EJNMMI RADIOPHARMACY AND CHEMISTRY. 2024;9(1):35
- Article: JOURNAL OF NUCLEAR MEDICINE. 2024;65(5):700-707
- Article: NUCLEAR MEDICINE COMMUNICATIONS. 2024;45(5):389-395
- Journal article: EJNMMI RADIOPHARMACY AND CHEMISTRY. 2024;9(1):35
- Article: EJNMMI RADIOPHARMACY AND CHEMISTRY. 2023;8(1):42
- Article: EJNMMI RADIOPHARMACY AND CHEMISTRY. 2023;8(1):41
- Journal article: NUCLEAR MEDICINE AND BIOLOGY. 2023;126:108801
- Journal article: NUCLEAR MEDICINE AND BIOLOGY. 2023;126:108455
- Journal article: NUCLEAR MEDICINE AND BIOLOGY. 2023;126:108673
- Journal article: NUCLEAR MEDICINE AND BIOLOGY. 2023;126:108721
- Journal article: NUCLEAR MEDICINE AND BIOLOGY. 2023;126:108800
- Journal article: NUCLEAR MEDICINE AND BIOLOGY. 2023;126:108529
- Journal article: ANNALS OF ONCOLOGY. 2023;34:s384
- Article: EJNMMI RESEARCH. 2023;13(1):73
- Article: JOURNAL OF NUCLEAR MEDICINE. 2023;64(8):1232-1237
- Article: CELL TRANSPLANTATION. 2023;32:9636897231212780
- Journal article: NUCLEAR MEDICINE AND BIOLOGY. 2022;108:s122-s123
- Journal article: NUCLEAR MEDICINE AND BIOLOGY. 2022;108:s197-s198
- Journal article: NUCLEAR MEDICINE AND BIOLOGY. 2022;108:s132-s133
- Journal article: NUCLEAR MEDICINE AND BIOLOGY. 2022;108:s216-s217
- Article: PHARMACEUTICALS. 2021;14(12):1251
- Article: MOLECULAR IMAGING AND BIOLOGY. 2021;23(6):952-962
- Article: APPLIED RADIATION AND ISOTOPES. 2021;176:109825
- Article: BIOMOLECULES. 2021;11(8):1118
- Article: JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS. 2021;64(8):346-352
- Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(3):617-629
- Article: INTERNATIONAL JOURNAL OF NANOMEDICINE. 2020;15:6137-6152
- Article: ANTIOXIDANTS AND REDOX SIGNALING. 2019;30(14):1746-1759
- Article: THERANOSTICS. 2019;9(8):2129-2142
- Journal article: FREE RADICAL BIOLOGY AND MEDICINE. 2018;120:s99-s100
- Article: PHYSICS IN MEDICINE AND BIOLOGY. 2017;63(1):015026
- Article: SCIENTIFIC REPORTS. 2017;7(1):4824
- Article: EJNMMI RESEARCH. 2016;6(1):27
- Article: NUCLEAR MEDICINE AND BIOLOGY. 2015;42(4):375-380
- Article: JOURNAL OF NUCLEAR MEDICINE. 2015;56(3):444-449
- Article: AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2015;5(4):333-347
- Article: APPLIED RADIATION AND ISOTOPES. 2014;94:294-301
- Article: EJNMMI RESEARCH. 2014;4(1):51
- Article: AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2014;4(4):311-323
- Article: AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2013;4(1):60-69
- Article: JOURNAL OF NUCLEAR MEDICINE. 2012;53(6):953-960
- Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2011;39(2):353-359
- Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2010;37(2):260-269
- Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2009;36(11):1864-1873
- Article: JOURNAL OF NUCLEAR MEDICINE. 2009;50(5):781-789
- Article: BIOCONJUGATE CHEMISTRY. 2008;19(12):2568-2576
- Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2008;35(12):2245-2255
- Article: BIOCONJUGATE CHEMISTRY. 2007;18(6):1956-1964
- Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2007;34(11):1843-1853
- Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2007;20(3):397-404
- Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2007;34(5):722-733
- Article: CANCER RESEARCH. 2007;67(5):2178-2186
- Article: BIOCONJUGATE CHEMISTRY. 2007;18(2):549-558
- Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2007;19(3):485-493
- Show more
All other publications
- Letter: JOURNAL OF NUCLEAR MEDICINE. 2023;64(11):1841
- Preprint: RESEARCH SQUARE. 2023
- Review: EJNMMI RESEARCH. 2023;13(1):43
- Conference publication: NUCLEAR MEDICINE AND BIOLOGY. 2023;126:S46
- Conference publication: NUCLEAR MEDICINE AND BIOLOGY. 2023;126:S301
- Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2023;50(SUPPL 1):S493
- Editorial comment: CLINICAL NUCLEAR MEDICINE. 2022;47(7):644-645
- Corrigendum: MOLECULAR IMAGING AND BIOLOGY. 2022;24(3):510
- Book chapter: HANDBOOK OF NUCLEAR MEDICINE AND MOLECULAR IMAGING FOR PHYSICISTS. 2022;p. 1-11
- Conference publication: NUCLEAR MEDICINE AND BIOLOGY. 2022;108:S216-S217
- Conference publication: NUCLEAR MEDICINE AND BIOLOGY. 2022;108:S132-S133
- Conference publication: NUCLEAR MEDICINE AND BIOLOGY. 2022;108:S197-S198
- Conference publication: NUCLEAR MEDICINE AND BIOLOGY. 2022;108:S122-S123
- Review: JOURNAL OF CHROMATOGRAPHY A. 2020;1632:461611
- Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2019;46(SUPPL 1):S38-S39
- Conference publication: JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS. 2019;62:S551-S552
- Conference publication: EUROPEAN HEART JOURNAL. 2019;40:674
- Conference publication: 2016;:1-4
- Review: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2015;16(12):30309-30320
- Conference publication: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2015;36:S115
- Conference publication: JOURNAL OF NUCLEAR MEDICINE. 2015;56(3)
- Conference publication: JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS. 2015;58:S24
- Conference publication: 2014;:1-3
- Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2014;41:S412
- Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2014;41:S280
- Conference publication: JOURNAL OF NUCLEAR MEDICINE. 2014;55
- Conference publication: JOURNAL OF NUCLEAR MEDICINE. 2014;55
- Conference publication: JOURNAL OF NUCLEAR MEDICINE. 2014;55
- Conference publication: JOURNAL OF NUCLEAR MEDICINE. 2014;55
- Conference publication: JOURNAL OF NUCLEAR MEDICINE. 2014;55
- Conference publication: JOURNAL OF NUCLEAR MEDICINE. 2013;54
- Conference publication: AIP CONFERENCE PROCEEDINGS. 2012;1509(1):206-210
- Conference publication: JOURNAL OF NUCLEAR MEDICINE. 2012;53
- Editorial comment: ZDRAVNIŠKI VESTNIK. 2011;80(12):969-970
- Conference publication: JOURNAL OF NUCLEAR MEDICINE. 2011;52
- Show more
Grants
- Swedish Research Council1 January 2024 - 31 December 2027
- Swedish Research Council1 December 2023 - 30 November 2026
- Swedish Cancer Society1 January 2023
- Swedish Heart-Lung Foundation1 January 2021 - 31 December 2021
- Clinical implementation of improved PSMA-based radiopharmaceuticals for the diagnosis and treatment of advanced prostate cancer.Region Stockholm1 January 2019 - 31 December 2019
- Swedish Research Council1 January 2018 - 31 December 2020
Degrees and Education
- PhD, Docent, Oncology and Pathology, Karolinska Institutet, 2016